High Dose Atorvastatin for Preventing Contrast-induced Nephropathy

Status Completed

Clinical Trial Summary

The aim of this study is to determine the efficacy of atorvastatin in the prevention of contrast-induced nephropathy in patients undergoing computed tomography coronary angiography. Investigators assume that atorvastatin is effective in this regard. Investigators include patients referring for elective computed tomography coronary angiography and allocate them to atorvastatin or placebo from 24 hours before to 48 hours after administration of contrast material. Investigators then measure serum creatinine and see if it is raised by ≥ 0.5 mg/dL or ≥ 25% of the baseline value.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02114346
Study type	Interventional
Source	Isfahan University of Medical Sciences
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	July 2013
Completion date	February 2014

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04877847` - Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury	N/A
Recruiting	`NCT02088502` - Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy	Phase 2/Phase 3
Completed	`NCT03329443` - The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography	Phase 2
Recruiting	`NCT04864847` - Clinical Validation of the RENISCHEM L-FABP POC Assay
Completed	`NCT03627130` - The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy	Phase 2
Active, not recruiting	`NCT03736018` - Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients	N/A
Withdrawn	`NCT04603261` - Time to Excretion of Contrast, a Maastricht Prospective Observational Study
Withdrawn	`NCT04598516` - Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30
Recruiting	`NCT03755700` - Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization	Phase 3
Active, not recruiting	`NCT04606056` - Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans
Terminated	`NCT02440646` - Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging
Completed	`NCT00175227` - Prevention of Contrast-Induced Nephropathy	N/A
Completed	`NCT04014153` - CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?
Withdrawn	`NCT04597892` - Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast
Completed	`NCT03305874` - Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization
Not yet recruiting	`NCT01871792` - Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction	Phase 4
Not yet recruiting	`NCT06429345` - Coenzyme Q10 Role in Prevention of Contrast Induced Nephropathy in Acute Coronary Syndrome Patients.	Phase 4
Recruiting	`NCT05271448` - Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography	N/A
Withdrawn	`NCT03806725` - Safety of Iodinated Contrast in Liver Transplant Candidates With Decreased Renal Function Undergoing Coronary CT Angiography
Completed	`NCT04163250` - Use of Urinary Cell-Cycle Arrest Biomarkers in Contrast-Associated Nephropathy After Coronary Angiography